首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>>
免疫调节
>>
免疫球蛋白/Fc相关
>
Human VSIG4 Protein, hFc Tag
Human VSIG4 Protein, hFc Tag

Human VSIG4 Protein, hFc Tag

产品编号

KMP2982

别名

含 V 组和免疫球蛋白结构域 4, Human VSIG4 Protein, hFc Tag, VSIG4

目录价格

联系客服获取报价RMB

规格
  • 50ug
  • 100ug
  • 200ug
产品介绍
Alias含 V 组和免疫球蛋白结构域 4, Human VSIG4 Protein, hFc Tag, VSIG4
Catalog NumberKMP2982
Product DescriptionThe Human VSIG4 Protein(KMP2982) is produced in HEK293 Cells. The target gene encoding the human VSIG4 (NP_009199.1) (Met1-Pro283) is expressed with the Fc region of human IgG1 at the C-terminus. The purified protein is biotinylated in vitro.
Molecular NameVSIG4
SpeciesHuman
HostHEK293 Cells
Size50ug, 100ug, 200ug
Protein FamilyOther protein
Purity>90% as determined by SDS-PAGE
Concentration联系销售经理获得最新批次的浓度
PurificationAffinity purification
Endotoxin<1.0 EU/ug determined by the LAL method
FormulationPBS, pH7.4
BackgroundVSIG4 (V-set and immunoglobulin domain containing 4), also known as complement receptor of the immunoglobulin superfamily (CRIg) and Z39Ig, is a type I transmembrane glycoprotein. It is a B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type I g domain and a truncated C-type I g domain. VSIG4 is exclusively expressed on tissue resident macrophages and binds to multimers of C3b and iC3b that are covalently attached to particle surfaces. No VSIG4 expression appears to be present in T and B cells. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. Mouse VSIG4 is synthesized as a 28 amino acid precursor that contains a signal sequence, a V-type I g domain (aa 36-115), one potential N-linked glycosylation site, and a single transmembrane domain. The V-type I g domain of mouse VSIG4 shares 86% and 8% aa sequence identity with the V-type I g domains of rat and human VSIG4, respectively.
ApplicationWB, ELISA
Recommended DilutionELISA: 1:100-1:1000
Cross-reactivityNo cross-reactivity with other antigens or proteins.
Predicted Molecular Weight56.2 kDa
Predicted N TerminusMet
ReconstitutionNot applicable. The product is supplied as a ready-to-use liquid formulation.
Storage ConditionAliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.
Remarks收到产品后请立即按保存条件储存;使用前短暂离心,使内容物集中于管底;避免反复冻融。
Shipping ConditionIn general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. If supplied as liquid, the proteins will be shipped with dry ice.
StabilitySamples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Molecular Weight56.2 kDa
Cross-reactivityNo cross-reactivity with other antigens or proteins.
Note仅供科研使用
ELISA IC50(ppb)≥ 1:1000
FunctionVSIG4 (V-set and immunoglobulin domain containing 4), also known as complement receptor of the immunoglobulin superfamily (CRIg) and Z39Ig, is a type I transmembrane glycoprotein. It is a B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type I g domain and a truncated C-type I g domain. VSIG4 is exclusively expressed on tissue resident macrophages and binds to multimers of C3b and iC3b that are covalently attached to particle surfaces. No VSIG4 expression appears to be present in T and B cells. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. Mouse VSIG4 is synthesized as a 28 amino acid precursor that contains a signal sequence, a V-type I g domain (aa 36-115), one potential N-linked glycosylation site, and a single transmembrane domain. The V-type I g domain of mouse VSIG4 shares 86% and 8% aa sequence identity with the V-type I g domains of rat and human VSIG4, respectively.
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
Temperature Range-20℃ ~ -80℃
Solubility产品为即用型液体,无需复溶。
AppearanceLiquid
Product Full NameHuman VSIG4 Protein
Preservative SolutionPBS, pH7.4
Usage Method冻干粉请按“复溶”说明用无菌去离子水复溶后使用,液体产品可直接使用;具体工作浓度请参考“推荐稀释比例”。
TargetVSIG4

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价